Gold nanoparticles can spot biomarker for blood clots

04/12/2010 | MIT Technology Review

Scottish scientists have developed gold nanoparticles that enable them to measure concentrations of thrombin, a protein linked to blood clots, in blood specimens using laser light. They hope the technology leads to tests in which patients are implanted with nanosensors to help detect blood clots and other diseases.

View Full Article in:

MIT Technology Review

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY